QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

ACHV

QT—Achieve Life Sciences, Inc.
NASDAQ·Healthcare·Biotechnology·Canada
Latest market price
4.85
-0.51-9.51%
OverviewShort InterestFilings
ACHVAchieve Life Sciences, Inc.·NASDAQ
OverviewShort InterestFilings
4.85-9.51%
TA
Loading chart...
Screen all →
VRTX-1.60%$451.63REGN+0.33%$609.94ARGX-1.63%$877.72ALNY-1.64%$278.09RVMD+3.31%$162.99MRNA+3.50%$63.96UTHR-2.70%$536.59BNTX-1.44%$90.89
Snapshot
Index-P/E-EPS (ttm)
-
Insider Own-
Shs Outstand102.66M
Perf Week-12.14%
Market Cap550.25MForward P/E-EPS next Y-0.46Insider Trans0.00%Shs Float-Perf Month8.99%
Enterprise Value-PEG-EPS next Q-Inst Own-Short Float-Perf Quarter18.58%
Income-P/S-EPS this Y-Inst Trans-Short Ratio-Perf Half Y10.73%
Sales-P/B-EPS next Y35.48%ROA-Short Interest-Perf YTD-2.41%
Book/sh0.11P/C-EPS next 5Y-ROE-52W High6.16 -21.27%Perf Year62.75%
Cash/sh0.28P/FCF-EPS past 3/5Y-ROIC-52W Low2.00 142.50%Perf 3Y-
Dividend Est.-EV/EBITDA-Sales past 3/5Y-Gross Margin-Volatility5.47% 5.16%Perf 5Y-
Dividend TTM-EV/Sales-EPS Y/Y TTM-Oper. Margin-ATR (14)0.42Perf 10Y-
Dividend Ex-Date-Quick Ratio-Sales Y/Y TTM-Profit Margin-RSI (14)44.37Recom2.00
Dividend Gr. 3/5Y-Current Ratio-EPS Q/Q-SMA20-6.79%Beta1.91Target Price13.00
Payout-Debt/Eq-Sales Q/Q-SMA501.17%Rel Volume4.02Prev Close5.36
Employees25LT Debt/Eq0.50Earnings-SMA20012.04%Avg Volume1.73MPrice4.85
IPO DateOct 12, 1995Option/ShortYes / YesEPS/Sales Surpr.-Net Debt/EBITDA-Volume6,942,103Change-9.51%
Analyst Ratings
DateActionAnalystRatingTarget
Apr-20-26InitiatedCanaccordBuy$13
May-13-24ReiteratedOppenheimerOutperform$11
Nov-16-22ReiteratedMaxim GroupBuy$8.00
Latest News
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
FY 2017
12/31/2017
Total Revenue
000
Upgrade your experience to unlock full historical data
Cost of Goods Sold Incl. D&A
000
Gross Profit
000
Selling, General and Administrative Excl. Other321611
Research and Development232316
Other Operating Expense000
Operating Income-55-39-27
Interest Expense123
Unusual Expense
———
Non-Operating Income (Expense)-1-10
Net Income Before Taxes-55-40-30
Income Taxes
000
Consolidated Net Income-55-40-30
Net Income From Continuing Operations-55-40-30
Net Income-55-40-30
EPS (Recurring)-1.25-1.24-1.50
EPS (Basic, Before Extraordinaries)-1.25-1.24-1.50
EPS (Diluted)-1.25-1.24-1.50
EBITDA-54-37-27
Other After Tax Adjustments
———
Stock Option Compensation Expense
———
Price To Earnings Ratio
———
Price To Sales Ratio
———
Gross Margin
———
Operating Margin
———
Net Margin
———
Shares Outstanding443220
Market Capitalization219——
Operating Lease Expense
———
Insider Trading Volume
$5.30$4.52$3.74$2.96$2.18● Close Price0.00M0.27M0.54M0.81M1.08MUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Oki Mark KChief Financial OfficerSep 18 '25Option Exercise0.00336,0000178,000Sep 22 12:00 AM
Oki Mark KChief Financial OfficerSep 18 '25Sale2.9250,060146,175127,940Sep 22 12:00 AM
Stewart Richard AlistairChief Executive OfficerSep 18 '25Option Exercise0.00455,0000358,376Sep 22 12:00 AM
Stewart Richard AlistairChief Executive OfficerSep 18 '25Sale2.92129,501378,143228,875Sep 22 12:00 AM
Wan JerryPrincipal Accounting OfficerSep 04 '25Option Exercise0.0068,200046,764Sep 08 12:00 AM
Wan JerryPrincipal Accounting OfficerSep 04 '25Sale2.7714,07038,97432,694Sep 08 12:00 AM
KING THOMAS BRAXTONDirectorSep 04 '25Option Exercise0.00910,0000455,000Sep 08 12:00 AM
KING THOMAS BRAXTONDirectorSep 04 '25Sale2.77139,858387,407315,142Sep 08 12:00 AM
JACOBS CINDYPresident & CMOSep 04 '25Option Exercise0.00220,0000143,214Sep 08 12:00 AM
JACOBS CINDYPresident & CMOSep 04 '25Sale2.7727,62976,532115,585Sep 08 12:00 AM
Xinos JaimeChief Commercial OfficerSep 04 '25Option Exercise0.00138,000095,286Sep 08 12:00 AM
Xinos JaimeChief Commercial OfficerSep 04 '25Sale2.7720,85457,76674,432Sep 08 12:00 AM
Oki Mark KChief Financial OfficerMar 17 '25Buy2.8910,00028,88710,000Mar 19 12:00 AM
Stewart Richard AlistairChieve Executive OfficerMar 17 '25Buy2.8610,00028,59860,876Mar 19 12:00 AM
Wan JerryPrincipal Accounting OfficerApr 19 '24Option Exercise0.0011,250012,057Apr 23 12:00 AM
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR